Trial Profile
Antiretroviral Therapy and the Hepatitis C Virus.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jan 2012
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis C; HIV infections
- Focus Therapeutic Use
- 24 Jan 2012 Actual patient number (18) added as reported by ClinicalTrials.gov.
- 24 Jan 2012 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
- 24 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.